The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 26th 2025
New research confirms hydroxyurea's long-term effectiveness in reducing hospital visits for children with sickle cell anemia, supporting its use as standard treatment.
Expert: The Fight for Provider Status for Pharmacists ‘Has Just Begun’
April 28th 2021Pharmacy Times® interviewed Scott J. Knoer, MS, PharmD, FASHP, the EVP and CEO of APhA, on how the recently introduced Pharmacy and Medically Underserved Area Enhancement Act may impact pharmacy and health care outlooks.
Watch
Johnson & Johnson Commits to Helping Eradicate Racial, Social Injustice in Health Care
April 27th 2021According to Michael Sneed, executive vice president of global corporate affairs and chief communication officer for Johnson & Johnson, the health care system has chronically left people of color behind, and the inequities seen throughout the COVID-19 pandemic are only the latest examples.
Read More
Patient and Provider Safety is at the Core of Mass COVID-19 Immunization Effort
April 27th 2021As new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Read More
More Than 100 Patient Groups Advocate for Affordable Prescription Drugs
April 27th 2021Patient and provider organizations urge the Department of Health and Human Services and the Biden administration to enact policies and protections that improve prescription drug affordability for people in the United States.
Read More
USP Outlines the COVID-19 Vaccine Handling Toolkit for World Immunization Week
April 26th 2021For World Immunization Week, Pharmacy Times® interviewed Nurisha Wade, MBA, VP of Global Healthcare Quality & Safety Center of Excellence at US Pharmacopeia (USP), and Farah Towfic, PharmD, MBA, director, CEO of Operations at USP, on USP’s COVID-19 Vaccine Handling Toolkit.
Watch
‘Pharmacy Is Literally Saving the World Through Immunizations,’ Says APhA CEO, EVP Scott Knoer
April 26th 2021Pharmacy Times® interviewed Scott J. Knoer, MS, PharmD, FASHP, the EVP and CEO of the American Pharmacists Association, on the Pharmacy and Medically Underserved Area Enhancement Act that was recently introduced in Congress.
Watch
Study: Previous COVID-19 Infection Doesn’t Fully Protect Against Reinfection in Young People
April 26th 2021The study found that more than 10% of participants who were previously infected with SARS-CoV-2 (seropositive) became reinfected, compared with new infections in 50% of participants who had not been previously infected (seronegative).
Read More
The POETYK PSO-1 and POETYK PSO-2 trials, which evaluated deucravacitinib 6 mg once daily, met both co-primary endpoints versus placebo, with significantly more patients achieving Psoriasis Area and Severity Index (PASI) 75 response and a static Physician's Global Assessment score of clear or almost clear (sPGA 0/1) after 16 weeks of treatment with deucravacitinib.
Read More